Published on
May 7, 2020
- 20:08 GMT
Coherus BioSciences Reports First Quarter 2020 Financial Results
– First Quarter UDENYCA® Net Sales of $116.2 Million – –Net Income of $35.6 Million – – Non-GAAP Net Income of $49.8 Million – REDWOOD CITY, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), …
Distribution channels:
Business & Economy, Technology
...
